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Abstract: Significant evidence supports an association between periodontal pathogenic bacteria 
and preterm birth and preeclampsia. The virulence properties assigned to specific oral pathogenic 
bacteria, for example, Fusobacterium nucleatum, Porphyromonas gingivalis, Filifactor alocis, 
Campylobacter rectus, and others, render them as potential collaborators in adverse outcomes 
of pregnancy. Several pathways have been suggested for this association: 1) hematogenous 
spread (bacteremia) of periodontal pathogens; 2) hematogenous spread of multiple mediators of 
inflammation that are generated by the host and/or fetal immune response to pathogenic bacteria; 
and 3) the possibility of oral microbial pathogen transmission, with subsequent colonization, in 
the vaginal microbiome resulting from sexual practices. As periodontal disease is, for the most 
part, preventable, the medical and dental public health communities can address intervention 
strategies to control oral inflammatory disease, lessen the systemic inflammatory burden, and 
ultimately reduce the potential for adverse pregnancy outcomes. This article reviews the oral, 
vaginal, and placental microbiomes, considers their potential impact on preterm labor, and the 
future research needed to confirm or refute this relationship.
Keywords: periodontal disease, preterm labor, oral microbiome, vaginal microbiome, bacteria, 
pregnancy, infant, premature birth, low birth weight
Introduction
Julius Richard Petri introduced the Petri dish to microbiology in 1887,1 making the 
culturing of single or multiple microbes on a nutrient medium in a Petri dish to be a 
130-year-old technology. However, bacteria seldom occur in nature as a pure culture 
of a single species, but rather exist and participate in a community of microbes, that 
is, the microbiome.2 In the case of a human host, the microbiome occupies several 
specific anatomic niches, for example, hair, skin, gastrointestinal tract, urogenital tract, 
vagina, nasal, and paranasal sinuses, and the oral cavity.2–4 Under the best of conditions, 
each of these microbiome niches represents a species-balanced community which is 
important to the establishment and maintenance of human health.3,5
Current evidence suggests an association between a dysbiotic oral microbiome, 
manifest as periodontal disease, and a variety of systemic diseases. For example, moder-
ate and severe periodontitis have been associated with development and progression of 
atherosclerosis,6–8 cardiovascular disease,9–11 stroke,12–14 complications of diabetes,15–17 
Alzheimer’s disease,18–20 and adverse pregnancy outcomes.21–27 The common denomina-
tor for this mixture of disease associations appears to be the host inflammatory response 
and specific microbial pathogens.28–30 Because inflammatory periodontal disease 
is, for the most part, preventable,31 intervention strategies that result in better oral/
systemic health should be considered for reasons of public health. More specifically, 
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such strategies should be aimed at populations susceptible to 
atherosclerosis-related diseases (ie, cardiovascular, stroke, 
diabetes, and possibly Alzheimer’s disease) and women of 
child-bearing age.
Significant evidence is available to consider that the 
majority of preterm births due to infection result from an 
ascendancy of bacterial pathogens from the vaginal micro-
biome to infect the clinically sterile intrauterine cavity 
consisting of the placenta, amniotic fluid, and fetus.31–34 
This does not preclude the possibility of a hematogenous 
spread (bacteremia) of pathogenic microbes and inflamma-
tory mediators originating from other sources, including 
untreated periodontal disease, and their contributions to an 
adverse pregnancy outcome, such as preeclampsia, preterm 
birth and low birth weight, fetal growth restriction, and 
fetal loss.30,35,36
The oral microbiome
As a result of multiple ecologic determinants, the human oral 
cavity presents a prodigious and multifarious microbiota.37–41 
In a state of health, the oral microbiota maintain a symbiotic 
relationship with their host. However, an imbalance or mal-
adaptation within the oral microbial community (dysbiosis) 
commonly results in development of a dental disease.42,43 
In this regard, dental caries, gingivitis, and chronic or aggres-
sive forms of periodontitis are the most common expressions 
of oral disease.39,44–46
Chronic periodontitis is a highly prevalent, dysbiosis-
initiated, inflammatory condition that results in destruction of 
the supporting tissues of the teeth. This destructive process, 
a host response to pathogenic bacteria and their toxins such 
as cytolytic enzymes and lipopolysaccharides, is mediated by 
a proinflammatory cellular response involving neutrophils, 
lymphocytes, macrophages, and osteoclasts.45–50 The host 
response also generates a variety of inflammatory media-
tors, such as interleukin (IL)-1β, tumor necrosis factor-α, 
IL-6, prostaglandin E2, matrix metalloproteinase-8 and -9, 
which, in turn, can have a downstream effect on other 
organ systems by contributing to the body’s overall inflam-
matory burden.51–56
Through reverse transcription-polymerase chain reaction, 
microarray, and pyrosequencing technology, the microbiome 
of the human oral cavity has been found to be made up of a 
minimum of 700+ distinct microbial species, with sugges-
tions that this number may be as high as 1,200–1,500.39–41 By 
comparison, the microbial flora consistently associated with 
chronic periodontitis is reported to involve only a limited 
number of species.39,40,57 Dominating, in terms of virulence, 
among the periodontitis-associated bacterial species are 
mainly Gram-negative anaerobic bacteria, such as Porphy-
romonas gingivalis, Filifactor alocis, multiple species of 
Prevotella, particularly, Prevotella intermedia, Tannerella 
forsythia, multiple species of Treponema, particularly, 
Treponema denticola, Aggregatibacter actinomycetemcomi-
tans, Fusobacterium nucleatum, Parvimonas micros, Campy-
lobacter recta, multiple species of Eubacterium, and multiple 
species of Bacteroides.37,39–41,57–59 Interestingly, two of these 
bacteria are considered “keystone” microbes, Po. gingivalis 
and Fi. alocis. Keystone microbes are characterized by their 
relatively low numbers in a biofilm community and inher-
ent virulence factors that allow manipulation of the host 
innate immune system and remodeling of a normally benign 
microbiota into one that is dysbiotic.42,60–64 In addition to 
being keystone microbes, both Po. gingivalis and Fi. alocis 
are highly invasive microbes, a virulence factor that allows 
avoidance of the host immune response.65–69 Other microbes 
associated with periodontitis (T. denticola, Pr. intermedia, 
Fu. nucleatum, A. actinomycetemcomitans, C. rectus, and 
so on) are also known to exhibit tissue-invasive tenden-
cies, particularly in severe disease.70–72 This combination of 
tissue invasiveness, when combined with multiple transient 
bacteremias (common in patients with periodontal disease 
during mastication, oral hygiene, or dental treatment) leads 
to a body-wide dissemination of bacteria and activation of 
systemic inflammation-causing organ system complications 
and, in the case of pregnancy, adverse outcomes.21,25,73–77
Prevalence of periodontitis
Combined data from the 2009 to 2010 and the 2011 to 2012 
cycles of the National Health and Nutrition Examination 
Survey revealed that 46% of US adults, aged 30 years, 
representing ~65 million people, exhibited some degree of 
periodontitis.78,79 Of this group, 8.9% presented with severe 
periodontitis, which equates to ~12.6 million people.79 
Increased prevalence rate of periodontitis was associated with 
increasing age, male gender, and current tobacco smoking. 
Prevalence rates based on ethnic grouping were rather reveal-
ing when considered in terms of access to care issues, that 
is, Hispanic (63.5%), non-Hispanic blacks (59.1%), non-
Hispanic Asian Americans (50%), and non-Hispanic whites 
(40.8) were predominantly affected.79
Worldwide, severe periodontitis is estimated to be pres-
ent in 10%–15% of the adult population,80,81 with prevalence 
varying considerably from country to country. For example, 
20% of adults between the ages of 20 and 79 years in a large 
West Pomerania (Germany) study were reported to exhibit 
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severe periodontitis.71 The same study reported a prevalence 
rate of 35.3% of the population presenting with moderate 
periodontitis.71
Studies from India report that prevalence of periodontitis 
with attachment loss of 3 mm (moderate to severe disease) 
varies from 46% to 78%.82 However, depending on the age 
group and rural vs urban populations, the prevalence of peri-
odontal disease in India can vary from ≈50% to a maximum 
of 91%.82–88 Periodontal disease prevalence data collected 
since the year 2000 and for women of reproductive age 
(18–45 years) are sparse. The data, not unexpectedly, show 
that both severity and prevalence of the disease increase with 
increasing age.83–88
Specific to reproductive aged women, Bansal et al,84 in 
their study that included 205 females, reported that 6.58% 
of those aged between 20 and 24 years exhibited bleeding 
on probing (BOP) and 50.61% of subjects aged between 
25 and 34 years presented with visible amounts of dental 
calculus. The authors did not address severity of disease in the 
traditional manner, but rather assessed the need for treatment 
using the Community Periodontal Index of Treatment Needs 
(CPITN).89 A CPITN score of 1= BOP; score of 2= presence of 
supra- or subgingival calculus; score of 3= periodontal probing 
depth of 3.5–5.5 mm; score of 4= probing depth 5.5 mm. 
Thus, based on the CPITN data, severity of disease in the 
Bansal et al84 study is judged to be slight to moderate.
Batra et al85 reported that 45.5% of females, in a rural 
population, aged 20–29 years and 83.9% of those aged 30–39 
years had CPITN scores of 2 or greater. Such a range of 
scores would indicate periodontal disease severity ranging 
from slight to severe.
Other studies addressing disease prevalence in women 
of reproductive age are equally imprecise. For example, 
studies by Grewal et al87 and Rao et al88 both assessed rural 
Indian populations from Punjab and Mustabad, Krishna 
District, respectively. One study used the CPITN87 and 
the other the Community Periodontal Index88 indices for 
screening of patients and approximation of disease severity. 
Females represented ≈55% of the population in both studies. 
In general, both studies reported that females, regardless of 
age group, had a greater prevalence of periodontal disease 
than did males, roughly 55% vs 44%.
A study by Murthy et al90 assessed the association of 
periodontal disease to preterm birth and low birth weight. 
The study evaluated 240 primigravida Indian women equally 
divided between those with and without periodontitis. All 
participants exhibited BOP, 48% exhibited dental calculus 
accumulation, and those with periodontitis had pocketing of 
3.5–4.5 mm (slight to moderate disease). The study reported 
that periodontitis and anemia were independent risk factors 
for low birth weight, in spite of the slight to moderate severity 
of periodontal disease.
The CPITN index has been used by the majority of 
epidemiology studies to express severity of disease and 
treatment needs in Indian populations. However, as noted 
by Chandra et al86 and Shewale et al,91 the CPITN is known 
to grossly underestimate the levels of moderate and severe 
disease. Given the presentation of data using CPITN from 
various studies and the issue of underestimation of disease 
severity, one can still reasonably conclude that periodontal 
disease in Indian women of reproductive age (18–45 years) 
ranges from 10% to 35%, increasing in both prevalence and 
severity with increasing age.
The vaginal microbiome
The Human Microbiome Project (2012)92 reported that the 
vaginal microbiome exhibits an uncomplicated microbial 
diversity, compared to that of the gastrointestinal tract or the 
oral cavity. In healthy subjects, there appears to be minimal 
variation in the diversity of the vaginal microbiota.93 Species 
of Lactobacillus typically dominate the vaginal microbiota, 
comprising greater than 70% of the microflora.94 As in other 
bacterial communities, the dominance of one or more species, 
in this case Lactobacilli, generally prevents colonization by 
undesirable extrinsic species and, thereby, may provide a 
protective function.93–96 Yet, Hyman et al97 report that changes 
in the proportions of Lactobacillus in the vaginal microbiome 
and the presence of noxious bacteria were not correlated 
to preterm birth. The authors noted that race/ethnicity and 
sampling location likely impact determination of the vaginal 
microbiome. This latter statement was supported by Green 
et al98 and Prince et al99 in their respective reviews in which 
it was noted that the vaginal microbiome can fluctuate during 
various states of health, during hormonal fluctuations (ie, 
menstrual cycle and menopause), and between women of 
various ethnicities. A recent study by Hickey et al100 further 
supports the impact of hormonal change on the vaginal 
microbiota, reporting that puberty and initiation of cyclic 
menstruation have profound effects. Last, Prince et al99 
reported that during pregnancy, there is an overall increase 
of bacteria from the taxa of Lactobacillus, Clostridiales, 
Bacterodies, and Actinomycetales. However, none of these 
taxa were noted as having any negative effects on pregnancy. 
Prince et al99 did note that most of the studies looking at the 
vaginal microbiome are cross-sectional, which allows for the 
characterization of a pregnancy and gestational age-common 
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microbiome, but lacks the capacity for description of dynamic 
changes that may occur in individuals over time.
The placental microbiome
While the placenta has long been considered to be sterile in 
normal gestation,99 several authors93,101–104 have now reported 
that the placenta in healthy pregnancies has its own resident 
microbiome. Indeed, it appears that the presence of bacte-
rial infiltration of the placenta, without histologic evidence 
of infection, is not an unusual observation.101,103,104 Combs 
et al105,106 have shown that there is no association of preterm 
birth with a relatively benign intra-amniotic invasion of 
bacteria, that is, in the absence of inflammation. In contrast, 
preterm birth rates were higher in the presence of a combi-
nation of bacterial invasion and concomitant inflammatory 
response, indicated by elevated amniotic fluid levels of IL-6. 
Interestingly, in their initial study, Combs et al105 diagnosed a 
microbial infection or severe inflammation (defined as amni-
otic fluid levels of IL-6 11.3 ng/mL) in 63 of 305 (≈20%) 
women with preterm labor. Of those identified with microbial 
infection (n=27), the offending microbe in roughly 50% of 
the patients was of a genus and species commonly found 
in the oral cavity, for example, Fu. nucleatum, Bergeyella 
sp., Clostridium sp., Actinomyces sp., Peptostreptococcus 
(a.k.a. Parviomonas) sp., and Candida albicans.
Given this observation, one might argue that the mere 
presence of bacteria in the placenta is not the important 
determinant of preterm birth. Rather the specific types of 
bacterial populations present would seem to play a bigger 
role. For example, the presence of “keystone” microbes, such 
as Po. gingivalis and/or Fi. alocis, both having the ability to 
interact with previously benign microbes, converting them 
into active pathogens, may play a sinister role in microbial 
dysbiosis that leads to an adverse pregnancy outcome. Given 
this line of thought, it is interesting to note that Aagaard 
et al102 reported that the bacterial taxonomic profile of the 
placenta microbiome was more similar to that of the oral 
cavity than to skin, nasal, vaginal, or the gastrointestinal 
floras of nonpregnant control patients.
The placental microbiome was found to contain, 
among others, bacteria belonging to the following phyla: 
Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes, 
and Fusobacteria.102 The majority of bacterial species in 
these phyla are Gram-negative, anaerobic, and common to 
the human oral cavity. As suggested by Stout et al,101 the 
similarities of the two microbiomes (vaginal and oral) may 
indicate a hematogenous spread of the associated microbes. 
A hematogenous spread of oral microbes, in turn, presents 
the possibility of their participation in the pathogenic mecha-
nisms of preterm birth or other adverse pregnancy outcomes, 
such as preeclampsia or fetal death.24,107–112
Bacteria and adverse pregnancy 
outcomes
Infection-related preterm birth is reported as the leading cause of 
infant mortality and morbidity.110 Evidence indicates that ~40% 
of preterm births are vaginal and intrauterine infection related 
and ~50% are associated with intra-amniotic infections.97,113,114 
Given this background, an understanding of the origin of the 
offending bacteria and routes of invasion of the placenta and 
amniotic cavity becomes requisite. A review by Mendez et al32 
concluded that the most common intra-amniotic bacterial taxa 
were species associated with the vagina, although other species 
were commonly associated with the oral cavity, gastrointestinal 
and respiratory tracts. The authors concluded that the collective 
data indicate a primary role for the ascending route of infec-
tion during pregnancy and a possible secondary role for the 
hematogenous route of invasion.
In spite of the evidence and the biologic plausibility 
supporting a hematogenous dissemination of oral microbes 
and a role in adverse pregnancy outcomes,115–118 a paradox 
remains. Results of intervention studies in which periodontal 
disease was treated in the second trimester of pregnancy 
have generated conflicting results.30,119–127 Reasons for this 
lack of effect may involve several design and methodology 
issues, such as 1) variations in the comprehensive nature of 
the periodontal examination, that is, partial vs full-mouth 
examination, which result in an imprecise determination of 
disease severity; 2) variations in the consistency in timing 
of the periodontal examination with respect to gestational 
age; 3) lack of masking of examiners; 4) lack of multivari-
able analyses that considered confounders30; 5) variations in 
treatment protocols; 6) treatment failed to adequately reduce 
periodontal inflammation; and 7) treatment rendered in the 
second trimester may be too late to elicit a beneficial effect on 
pregnancy outcomes. The obvious intervention study remains 
to be done, that is, definitive treatment of inflammatory peri-
odontal disease prior to conception, followed by periodontal 
maintenance every 3 months during pregnancy.
One might argue that the hematogenous spread of oral 
microbial pathogens (bacteremia) is prevented by systemic 
“biologic filters” such as the reticuloendothelial systems of 
the liver and spleen and the maternal–fetal barrier. How-
ever, multiple avenues exist for how bacteria of oral origin 
can participate in placental and intrauterine infections. 
Take for example, Fu. nucleatum, a highly prevalent oral 
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microbial species that is associated with both periodontal 
disease128,129 and adverse pregnancy complications.130,131 
Several investigators132,133 have shown that Fu. nucleatum can 
be induced to express adhesin FadA, a protein that interacts 
with E-cadherin which is a major mediator of cell-to-cell 
attachment of epithelial and endothelial cells. Fu. nucleatum 
adheres to and invades host cells and facilitates invasion by 
otherwise noninvasive bacteria.134–136 Indeed, host cell attach-
ment and invasion by Fu. nucleatum has been shown to play 
a critical role in intrauterine infection.133,136
A second consideration is the potential role for 
Po. gingivalis, mentioned earlier along with Fi. alocis, as 
a “keystone” microbe. Po. gingivalis has been detected 
in the amniotic fluid of pregnant females at risk for pre-
mature delivery137,138 and in the placentas of patients with 
preeclampsia.139 Immunohistochemistry techniques have 
shown that the microbe has a demonstrated presence in pla-
cental tissues, for example, syncytiotrophoblasts, chorionic 
trophoblasts, decidual cells, amniotic epithelial cells, and 
endothelial cells, obtained from subjects diagnosed with 
chorioamnionitis. Last, animal studies have demonstrated the 
ability of Po. gingivalis to achieve transplacental passage, 
resulting in chorioamnionitis and placentitis.140,141
A third conceivable pathway for establishment of oral 
microbial pathogens in the vaginal, microbiome which, in a 
pregnancy may contribute to the placental microbiome, can 
be explained by direct transmission through sexual practices. 
This latter pathway does not seem to have been addressed in 
the research literature.
Regardless of the origin, infections leading to adverse 
pregnancy outcomes that involve bacteria common to the 
oral cavity raise at least two relevant questions from a public 
health viewpoint:
1. Will preconception treatment of periodontal disease, 
that is, reduction of inflammation, bacterial loads, and 
inflammatory mediators, in a reproductive age female, 
reduce the incidence of adverse pregnancy outcomes?
2. Given the possibility of transmission of oral pathogenic 
microbes during sexual activities, will preconception 
treatment of periodontal disease in both partners reduce 
the incidence of adverse pregnancy outcomes?
Given the cost of dental care in the US and some other 
developed countries, the maldistribution of dental practitio-
ners in urban vs rural localities, and the lack of dental care 
in many underdeveloped countries, a profound disparity 
exists in access to dental care and in periodontal health in 
poor and/or rural populations.142–150 Assuming that research 
initiatives will eventually answer the two questions listed 
above, the medical and dental public health communities still 
need to develop strategies to address access to care.
Conclusion
Significant evidence supports an association between the dis-
semination of pathogenic bacteria associated with moderate 
and severe periodontitis and extraoral infections and inflamma-
tion. The virulence properties assigned to specific oral patho-
genic bacteria, for example, Fu. nucleatum, Po. gingivalis, 
Fi. alocis, C. rectus, and others, render them as potential 
collaborators in adverse outcomes of pregnancy.21,151–154 The 
biologic plausibility of the association between periodontal 
disease, the inherent bacteria and systemic impact of inflam-
matory mediators, and adverse pregnancy outcomes likely 
involves several pathways: 1) a hematogenous spread (bacte-
remia) of periodontal pathogens;151 2) a hematogenous spread 
of multiple mediators of inflammation that are generated by the 
host and/or fetal immune response to pathogenic bacteria;116,155 
and 3) a possible oral microbial pathogen transmission, with 
subsequent colonization, in the vaginal microbiome resulting 
from sexual practices. The medical and dental public health 
communities should address intervention strategies aimed at 
controlling oral inflammatory disease, which will lessen the 
systemic inflammatory burden and suppress the potential for 
adverse pregnancy outcomes.
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